Levels of whole salivary advanced glycation end products and interleukin-17 and peri-implant clinical and radiographic status in patients with osteoporosis at 6-years’ follow-up
Open Access
- 24 November 2022
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Oral Health
- Vol. 22 (1), 1-8
- https://doi.org/10.1186/s12903-022-02591-7
Abstract
There are no studies that have assessed advanced glycation end products (AGEs) and interleukin 17A (IL-17A) levels in whole saliva (WS) of patients with dental implants. The aim was to compare levels of AGEs and IL-17A in WS and peri-implant clinical and radiographic status of patients with and without osteoporosis at 6-years’ follow-up. Osteoporotic (Group-1) and systemically healthy controls (Group-2) having undergone dental implant therapy at least 5 years ago were included. A questionnaire was used to collect information about age, gender, duration and treatment of osteoporosis, number and duration of implants in function, and frequencies of toothbrushing, flossing and hygiene visits. Modified bleeding and plaque indies (mBI and mPI), peri-implant probing depth (PD) and crestal bone loss (CBL) were recorded. WS was collected and levels of AGEs and IL-17A were determined using enzyme linked immunosorbent assay. Sample-size estimation was done and statistical analyses were doing using the independent t- and Wilcoxon rank-sum tests. Statistical significance was marked for P-values that were below 0.01. In patients with (n = 24) and without (n = 27) osteoporosis, implants were in function for 6.3 ± 0.27 and 6.6 ± 0.5 years, respectively. There was no significant difference in peri-implant mBI, PD, mPI and CBL in both groups. Levels of AGE in patients with (119.6 ± 26.5 μg/ml) and without (91.5 ± 14.6 μg/ml) osteoporosis were comparable. Levels of whole salivary IL-17A in patients without and with osteoporosis were 4.6 ± 0.3 and 5.1 ± 0.8 pg/ml, respectively. Flossing of full mouth interproximal spaces once and twice daily toothbrushing daily was reported by 100% patients with osteoporosis. Among patients with osteoporosis 75% and 25% individuals were receiving professional dental prophylaxis every 4 and 6 months, respectively. Within the limitations of the present study osteoporotic patients are not at an increased risk of peri-implant diseases and can demonstrate salivary AGE and IL-17A levels comparable to non-osteoporotic individuals as long as oral hygiene is stringently maintained.Keywords
This publication has 46 references indexed in Scilit:
- Smoking, Radiotherapy, Diabetes and Osteoporosis as Risk Factors for Dental Implant Failure: A Meta-AnalysisPLOS ONE, 2013
- Glycation and oxidative stress in the failure of dental implants: a case seriesBMC Research Notes, 2013
- Expression of IL-6, IL-10, IL-17 and IL-8 in the peri-implant crevicular fluid of patients with peri-implantitisArchives of Oral Biology, 2011
- Osseointegration of Dental Implants in Patients Undergoing Bisphosphonate Treatment: A Literature ReviewThe Journal of Periodontology, 2010
- Investigation of the Relationship between Type 2 Diabetes and Osteoporosis Using Bayesian InferenceJournal of Clinical Densitometry, 2007
- Comparison of Periodontal and Socioeconomic Status Between Subjects With Type 2 Diabetes Mellitus and Non‐Diabetic ControlsThe Journal of Periodontology, 2007
- Receptor for Advanced Glycation End Products, Inflammation, and Accelerated Periodontal Disease in Diabetes: Mechanisms and Insights Into Therapeutic ModalitiesAnnals of Periodontology, 2001
- Osteoporosis and Implant Failure: An Exploratory Case‐Control StudyThe Journal of Periodontology, 2000
- Enhanced Interaction of Advanced Glycation End Products With Their Cellular Receptor RAGE: Implications for the Pathogenesis of Accelerated Periodontal Disease in DiabetesAnnals of Periodontology, 1998
- Microscopic evaluation of clinical measurements of connective tissue attachment levelsJournal of Clinical Periodontology, 1977